A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy (Q74117541)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 May 2002
edit
Language Label Description Also known as
English
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
scientific article published on 01 May 2002

    Statements

    A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit